Posted 4 days ago

After an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted by the board after an accounting scandal at a foreign subsidiary. By forming

Tags: biotechnology

Posted 1 week ago

Guest content from John Avellanet, managing director and principal of Cerulean Associates:Managing suppliers is fraught with challenges. Rare is the executive who has not made a mistake. In this art

Tags: biotechnology

Posted 2 weeks ago

For those attending BIO2008, I ll be speaking on Friday morning:Title: Scientific Communications Trends and Liabilities Track: Public Relations/Investor Relations Date and Time: Friday, June 20

Posted 2 weeks ago

For those attending BIO2008 in San Diego this year, I ll be signing my books in the BIO bookstore on Wednesday June 18th from 10-11. There will also be a limited number of free copies of the Journa

Tags: biotechnology

Posted 3 weeks ago

Courtesy of DrugPatentWatch.com:Drug Patent Expirations in June 2008*Drugs may be covered by multiple patentsTradenameApplicantGeneric NamePatent NumberPatent ExpirationADALAT CCBayer Pharmsnifedipine

Tags: pharma

Posted 4 weeks ago

Guest content from Sandy Graham, managing partner at Sequoyah Associates:Can you see the field of opportunity? Have your clearly defined your plan to achieve your entrepreneurial dreams? Have yo

Tags: biotech

Posted 5 weeks ago

BiotechBlog provides a forum to promote your expertise through the publication of actionable industry guidance. See the submission guidelines for more information

Posted 5 weeks ago

The Journal of Commercial Biotechnology is looking for papers on investing strategies in the biotechnology space. The scope can include valuation models, strategies to identify under-valued companies,

Tags: biotechnology

Posted 6 weeks ago

For those attending BIO2008 in San Diego this year, I ll be doing a signing of my books on Wednesday June 18th from 10-11.I ll also be speaking on Friday:Title: Scientific Communications Trend

Posted 7 weeks ago

I ve nearly completed revisions for the third edition of Building Biotechnology, the leading textbook on the business of biotechnology. This new edition has several new chapters, new case studies, u

Tags: biotechnology